Similar studies, but in a different biological material, were conducted by Chudecka-Głaz et al. [38], who evaluated the concentration of selected cytokines, proteins, and growth, including osteoprotegerin in the peritoneal fluid of patients with ovarian cancer or benign gynaecological conditions. Here, TNFRSF11B is linked to ovarian carcinoma.